CA1001626A - Phenoxypropylamine derivatives and the preparation thereof - Google Patents

Phenoxypropylamine derivatives and the preparation thereof

Info

Publication number
CA1001626A
CA1001626A CA216,299A CA216299A CA1001626A CA 1001626 A CA1001626 A CA 1001626A CA 216299 A CA216299 A CA 216299A CA 1001626 A CA1001626 A CA 1001626A
Authority
CA
Canada
Prior art keywords
preparation
phenoxypropylamine derivatives
phenoxypropylamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA216,299A
Other languages
English (en)
Other versions
CA216299S (en
Inventor
Heimo Stormann-Menninger-Lerchenthal
Heribert Pittner
Gerhard Zolss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patheon Austria GmbH and Co KG
Original Assignee
Chemie Linz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz AG filed Critical Chemie Linz AG
Application granted granted Critical
Publication of CA1001626A publication Critical patent/CA1001626A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA216,299A 1973-12-20 1974-12-17 Phenoxypropylamine derivatives and the preparation thereof Expired CA1001626A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1066673A AT334385B (de) 1973-12-20 1973-12-20 Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen

Publications (1)

Publication Number Publication Date
CA1001626A true CA1001626A (en) 1976-12-14

Family

ID=3623884

Family Applications (1)

Application Number Title Priority Date Filing Date
CA216,299A Expired CA1001626A (en) 1973-12-20 1974-12-17 Phenoxypropylamine derivatives and the preparation thereof

Country Status (19)

Country Link
US (1) US4034009A (fr)
JP (2) JPS5412461B2 (fr)
AT (1) AT334385B (fr)
BE (1) BE823411A (fr)
CA (1) CA1001626A (fr)
CH (1) CH612417A5 (fr)
CS (1) CS185669B2 (fr)
DD (1) DD118421A1 (fr)
ES (1) ES433145A1 (fr)
FR (1) FR2255058B1 (fr)
GB (1) GB1441359A (fr)
IE (1) IE40310B1 (fr)
IL (1) IL46259A (fr)
LU (2) LU71514A1 (fr)
PL (1) PL94095B1 (fr)
RO (1) RO69147A (fr)
SU (1) SU547174A3 (fr)
YU (1) YU36492B (fr)
ZA (1) ZA748067B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177280A (en) * 1978-07-03 1979-12-04 Syntex (U.S.A.) Inc. Bicyclo[3.1.0]hexyl-substituted carbonylaminophenoxy cardiovascular agents
JPS5757231U (fr) * 1980-09-19 1982-04-03
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
DE3410380A1 (de) * 1984-03-21 1985-10-10 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
EP1545519B1 (fr) 2002-08-19 2011-03-23 Pfizer Inc. Therapie de combinaison pour maladies hyperproliferatives
CN1812983A (zh) * 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
WO2007029155A2 (fr) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Procede de preparation ameliore d'une base de celiprolol pure
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008020314A2 (fr) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Formulations de dosage stabilisantes à base de statine
WO2008010087A2 (fr) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited FORMES POLYMORPHES D'UN INHIBITEUR DE LA HMG-CoA-RÉDUCTASE ET LEURS UTILISATIONS
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (fr) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
CA2730603C (fr) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase utiles dans le traitement des affections gastro-intestinales, de l'inflammation gastro-intestinale, du cancer gastro-intestinal et d'autres affections
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1214012A (en) * 1967-12-21 1970-11-25 Allen & Hanburys Ltd Phenylethanolamines
FR8183M (fr) * 1967-12-22 1970-09-07
US3935259A (en) * 1970-01-08 1976-01-27 Ciba-Geigy Corporation New amines and processes for their manufacture
SE354851B (fr) * 1970-02-18 1973-03-26 Haessle Ab
NL7115581A (fr) * 1970-11-13 1972-05-16 Dresden Arzneimittel
GB1396322A (en) * 1971-06-15 1975-06-04 Ici Ltd Alkanolamine derivatives
GB1393675A (en) 1971-06-16 1975-05-07 Ici Ltd Alkanolamine derivatives
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
GB1460593A (en) * 1973-06-22 1977-01-06 Ici Ltd Ethanolamine derivatives
FI65987C (fi) * 1973-12-12 1984-08-10 Ici Ltd Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat
AT334386B (de) * 1973-12-21 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen

Also Published As

Publication number Publication date
LU88296I2 (fr) 1994-05-04
US4034009A (en) 1977-07-05
ATA1066673A (de) 1976-05-15
YU36492B (en) 1984-02-29
IE40310B1 (en) 1979-04-25
SU547174A3 (ru) 1977-02-15
AT334385B (de) 1976-01-10
FR2255058B1 (fr) 1978-07-28
IL46259A (en) 1978-04-30
JPS5412461B2 (fr) 1979-05-23
RO69147A (fr) 1981-07-30
ES433145A1 (es) 1976-11-16
YU327774A (en) 1982-02-25
AU7653874A (en) 1976-06-17
GB1441359A (en) 1976-06-30
BE823411A (fr) 1975-06-16
JPS5549071B2 (fr) 1980-12-10
CH612417A5 (fr) 1979-07-31
PL94095B1 (fr) 1977-07-30
FR2255058A1 (fr) 1975-07-18
IL46259A0 (en) 1975-03-13
JPS5095246A (fr) 1975-07-29
IE40310L (en) 1975-06-20
JPS53149947A (en) 1978-12-27
DD118421A1 (fr) 1976-03-05
LU71514A1 (fr) 1975-08-20
ZA748067B (en) 1976-01-28
CS185669B2 (en) 1978-10-31

Similar Documents

Publication Publication Date Title
CA1024088A (fr) Sels doubles de s-adenosile-l-methionine et leur preparation
ZA748067B (en) Phenoxypropylamine derivatives and preparation thereof
CA1022172A (en) Derivatives of 2-aminoindane, the preparation and use thereof
AU475887B2 (en) Purpuromycin and its derivatives
CA1036164A (fr) Synthese et emploi de derives du amino-2 indane
CA997765A (en) Derivatives of 2-amino-indane, the preparation and use thereof
CA997786A (en) Derivatives of 2-amino-indane, the preparation and use thereof
CA1001627A (en) Phenoxypropylamine derivatives and the preparation thereof
AU466441B2 (en) New cyclopentenoquinolone derivatives and the preparation thereof
AU477130B2 (en) Cyclic sulfoximides and the preparation thereof
AU483534B2 (en) Phenoxypropylamine derivatives andthe preparation thereof
AU477684B2 (en) Novel phenoxyalkylamine derivatives and preparation thereof
CA1021342A (en) Mercaptoalkylpyridines and derivatives
CA1022176A (en) Isopurpuromycin and its derivatives
AU458910B2 (en) Thiazolotriazolylphosphonothioates preparation and uses thereof
AU7375674A (en) Novel phenoxyalkylamine derivatives and preparation thereof
AU7286774A (en) 4-hydroxy-5-azacoumarin and derivatives
AU439063B2 (en) New phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof
AU459797B2 (en) 2-arylthiobenzoicacids and their preparation
AU483128B2 (en) Bis-triazinobenzimidazoles and their preparation
AU484225B2 (en) Cephem derivatives and preparation thereof
AU482409B2 (en) ALKYL-6, 7-DIALKOXY-2-METHYL-4-OXOTETRAHYDRODUINOLINE-l-CARBOXYLATES AND THEIR PREPARATION
CA1031326A (fr) Derives de desalanyltetaine et mode de fabrication
AU483822B2 (en) Butyramide derivatives and their preparation
AU489282B2 (en) New thiazolo-isoquinolines and the process for the preparation thereof